To explore the therapeutic potential of RXR activation for PD treatment, we utilized AAV-mediated transduction to deliver either human RXRα or the control GFP, alongside AAV/PFF, into the mouse SNpc. This evidence concerns the gene RXRA and Parkinson disease.